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Background: Cardiomyopathy is noted in up to 40% of infants of diabetic mothers, and the exact mechanisms
responsible for it are unknown. The aim of this study was to compare between infants of diabetic mothers (IDM)
and infants of non- diabetic mothers (INDM) as regards cardiac troponin I (cTnI) levels (as a marker of cardiac
dysfunction) and to examine the relationship between this marker and neonatal echocardiographic changes
(cardiac structure and function).
Methods: A prospective, comparative study included eighty full term neonates during the first three days of life,
during the period from April 2008 to June 2011. They were divided into 2 groups, group I: included 40 infants of
diabetic mothers (IDMs)and group II: included 40 infants of non diabetic healthy mothers as a control group.
Results: 37.5% of the IDMs were large for gestational age and demonstrated a significantly lower blood glucose
level than the control group (34.6 ± 11.3mg/dl Vs 77.2 ± 19.8 mg/dl respectively) , respiratory distress and cyanosis
were the presenting signs in 67.5% of IDMs. Cardiac TnI on the second day of life increased significantly in
infants of diabetic mothers in comparison to INDM (p < 0.006) . IDMs had a significant increase in left atrial
thickness ( 11.5 ± 1.8mm in IDM Vs 10.5 ± 0.9mm in INDM P < 0.002*) and a significant increase in septal thickness
(5.0 ± 1.2mm in IDM Vs 4.0 ± 0.5mm in INDM P < 0.001*). CTnI correlated positively with interventricular septum
thickness (P-value = 0.002*). Cardiac TnI was significantly increased in IDMs with respiratory distress (P –value < 0.05).
Conclusions: This study demonstrated a highly significant positive correlation between cTnI level on the second
day of life and the left ventricular end diastolic diameter (LVED) and interventricular septum diameter (IVSD).
Cardiac troponin I (cTnI) is a useful biochemical marker for monitoring myocardial injury in infants of diabetic
mothers. An elevated cTnI concentration in infants of diabetic mothers with respiratory distress was a good
predictor for hypertrophic cardiomyopathy and/or left ventricular dysfunction.
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Infant of a diabetic mother (IDM) is, defined as, a neo-
nate born to mother who had suffering from diabetes
mellitus, but this term refers specifically to the neonate
born to a woman who had persistently elevated blood
sugar during pregnancy [1]. Cardiovascular abnormal-
ities in infants of diabetic mothers occur in the form of
congenital heart diseases (3-5%), and cardiomyopathy
(10-20%) [2]. It is suggested that fetal hyperinsulinism
may trigger hyperplasia and hypertrophy of myocardial
cells by increasing fat and protein synthesis [3,4].
Troponin is a calcium-regulated, three subunit pro-
teins (Troponin C, Troponin I and Troponin T) involved
in the actin-myosin interaction in muscle cells, inhibit-
ing the ATPase activity of actomyocin, resulting in muscle
relaxation [5]. The serum levels of cardiac troponin I
(known to be a marker for cardiac injury) in infants of
diabetic mothers, were significantly elevated in symptom-
atic patients with life threatening respiratory or homody-
namic distress [6,7]. It is important to note that cardiac
troponin I is a marker of all heart muscle damage, not
just myocardial infarction. Troponins are increased in
several forms of cardiomyopathy, such as hypertrophic
cardiomyopathy or (left) ventricular hypertrophy, presum-
ably due to increased oxygen demand and inadequate
oxygen or blood supply to the heart muscle [8,9].
The aim of this study was to compare between infants
of diabetic and those of non- diabetic mothers as regards
cardiac troponin I (cTnI) levels (as a marker of cardiac
dysfunction) and to examine the relationship between
this marker and neonatal echocardiographic changes
(cardiac structure and function).Table 1 Comparison between diabetic and non-diabetic grou
IDM (Group1)
No.40
Gestational age (Weeks) 36.7 ± 0.6
Birth wt (Kg) 4.1 ± 0.6
APGAR 1 5.8 ± 0.5
APGAR 2 9.0 ± 0.0







RBS (mg/dl) 34.6 ± 11.3
# Independent t-test *significant.
α Chi square test &Mann Whitney test.
IDM: Infant of diabetic mothers, INDM: Infant of non diabetic mothers.
RBS: Random Blood Sugar.Methods
Study design
This is a prospective, comparative study.
Population
Eighty full term neonates were included in this study.
They were recruited from the neonatal intensive care
units , AL-Zahraa and Al-Hussein university hospitals,
during the period from April 2008 to June 2011. Sex,
birth weight, mode of delivery, Apgar score, cord acid–
base status, Downs Score (to assess the severity of
respiratory distress) was recorded.
They were divided into 2 groups: group I included
fourty infants of diabetic mother (IDMs), they were
25 males (62.5%) and 15 females (37.5%) and group II
included 40 infants of non diabetic healthy mothers
as a control group. They were 24 males (60%) and
16 females (40%).
Preterm neonates (less than 37 weeks), neonates with
major central nervous system, cardiac and/or pulmonary
anomalies, severe hypoxia, respiratory distress syndrome
(RDS) or neonatal sepsis were excluded from this study.
Mothers with history of hypertension, pre eclampsia,
rheumatic heart disease or drugs except insulin for
DM were excluded from the study. All deliveries
were attended by a neonatologist expert in techniques
of resuscitation. Apgar scoring at 1 and 5 minutes
were recorded in all, and none of the neonates had
birth asphyxia.
All studied groups were subjected to : full history
taking, clinical examination, estimation of troponin I




36.9 ± 0.9 1.169 0.245
3.4 ± 0.2 7.000 <0.001*
5.9 ± 0.3 1.085 0.281
9.0 ± 0.0 0.001 1.000
0.5 (0.0-2.0) -0.867& 0.386
24 (60.0%) 0.00 α 1.00
16 (40.0%)
20(50.0%) 0.813 α 0.367
20(50.0%)
77.2 ± 19.8 11.818# <0.001*
Figure 1 Distribution of cardiac troponin I concentrations for
infants of diabetic and non diabetic mothers. The red box is the
Table 2 cTnI in infants of diabetic and non diabetic






TnI ng/ml (1st) 1.0 (1.0-1.0) 1.0 (1.0-1.0) 0.000 1.000
TnI ng/ml (2nd) 1.2 (1.0-2.5) 1.0 (1.0-1.0) -2.742 0.006*
1st = (first day of life) 2nd = (second day of life).
* = Significant IQR = Interquartile range.
IDMs = Infants of diabetic mothers, INDMs = Infants of non diabetic mothers.
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http://www.ijponline.net/content/38/1/39immunoassay (CentaurW, Bayer) [9]. cTnI was measured
in the first and second days of life. The upper reference
limits for cTnI, defined as the 95% cut-off by nonpara-
metric analysis, were 0.1 ng/ml. cTnI values that exceed
1.5 ng/ml indicate myocardial necrosis compatible with
acute myocardial injury.interquartile range, and the dark dots in the middle of the box is the
median value.Echocardiography
Neonatal echocardiography was performed during the
first 3 days of life and cardiac measurements were deter-
mined by 2D and cross sectional M-mode echocardiog-
raphy. Cardiac structure / function were assessed within
the first three days of life by measuring left ventricle
end-diastolic dimension (LVEDD), left ventricle end-
systolic dimension (LVESD), ventricular septal thickness
(VST), posterior wall thickness (PWT), percentage of
ejection fraction (EF%) and percentage of shortening
fraction (SF%).We used Hewlett Packard SONOS 5500
with a 5.0 or 3.5 MHZ transducer.Statistical analysis
Cardiac troponin I concentrations were not normally dis-
tributed and therefore medians and interquartile ranges
are reported and non-parametric comparisons were
made using the unpair comparison t-test (for normally
distributed variables), Mann–Whitney U test (for non-
normally distributed variables). Categorical variables were
expressed in percentages. Categorical data were compared
using a χ2 test. A Nonparametric Spearman ρ test was
used to investigate the relationship between cTnI and car-
diac function and structure parameters and Doppler
indexes. P < 0.05 was considered statistically significant.Table 3 Relation between TnI (2nd) and clinical manifestation
Present
N Median (IQR) ng/ml N
Resp. distress 27 1.7 (1.0-2.5) 1
Cyanosis 24 1.1 (1.0-2.5) 1
*Significant IQR = Interquartile range.Results
Among the diabetic mothers 32.5% were type-1 DM,
40% type-2 DM, and 27.5% were gestational diabetes.
The demographic data of the studied groups are
summarized in (Table 1). The mean weight of IDM
was 4.1 ± 0.6Kg in comparison to 3.4 ± 0.2 Kg in INDM
(P < 0.001*), the blood glucose level in IDMs showed
a significantly lower level than INDM (34.6 ± 11.3mg/dl
Vs 77.2 ± 19.8 mg/dl, P < 0.05* respectively). Respiratory
distress and cyanosis were evident as a main clinical
manifestations of IDMs in (67.5% and 60% respec-
tively). On assessment of cTnI on the second day of
life, it was significantly elevated in IDM (Table 2 &
Figure 1), among them, infants with respiratory distress
have a higher cTnI levels than those without (median
values of 1.7ng/ml Vs 1.0 ng/ml respectively) (Table 3 &
Figure 2).
We found that the most common echocardiographic
findings in IDMs were asymmetrical septal hypertrophy
(80%), patent foramen ovale (PFO) (37.5%), and patent
ductus arteriosus (PDA) (27.5%). We found a significant
increase in left atrial thickness and interventricular
septal dimension in infants of diabetic mothers ins in infants of diabetic mothers
Absent z P
Median (IQR) ng/ml
3 1.0 (1.0-1.0) −2.984 0.003*
6 1.0 (1.0-1.8) −1.685 0.092
Figure 2 Distribution of cardiac troponin I concentrations for
infants of diabetic mothers with and without respiratory
distress. The box is the interquartile range, and the dark dots in the
middle of the box is the median value.
Table 4 Echocardiographgic measurements of neonates
in the studied groups
INDMs Mean ± SD IDMs Mean ± SD t ƛ P
LVSD (mm) 16.6 ± 2.1 16.6 ± 2.1 1.793 0.076
LVDD (mm) 10.5 ± 2.1 10.5 ± 2.1 1.601 0.113
FS % 37.4 ± 5.9 37.4 ± 5.9 0.816 0.416
EF % 70.5 ± 7.4 70.5 ± 7.4 2.928 0.0045
PWT (mm) 4.2 ± 1.3 4.2 ± 1.3 1.657 0.101
LA (mm) 11.5 ± 1.8 11.5 ± 1.8 3.143 0.0024*
IVSD (mm) 5.0 ± 1.2 5.0 ± 1.2 4.865 0.001*
HCMP 32 (80.0%) 32 (80.0%) 50.052 0.001*
PFO 15 (37.5%) 15 (37.5%) 0.813 0.367
PDA 11 (27.5%) 11 (27.5%) 2.625 0.105
* = Significant ƛ Independent t-test.
IDMs = Infants of diabetic mothers, INDMs = Infants of non diabetic mothers.
IQR = Interquartile range.
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and 5.0 ± 1.2mm Vs 4.0 ± 0.5mm respectively) (Table 4 &
Figures 3,4,5). Cardiac TnI was significantly higher in
IDMs with hypertrophic cardiomyopathy than without
(median = 1.3 Vs 1.0 , P = 0.004** respectively) (Table 5).
There was a significant positive correlation between
cardiac troponin I and both intraventriculer dimensions
and posterior wall diameter in IDMs (r = 0.423 P < 0.002** &r= 0.423 P<0.002**
Figure 3 Correlation between cTnI and intraventriculer dimensions.r = 0.260 P < 0.05 respectively) (Table 6, Figure 6,7). No
significant correlations between cardiac troponin I and
gestational age, birth weight, RBS, CRP, Apgar scores
cord and acid–base status were recorded (Table 7). No
relationship was observed between echocardiographic
evidence of hypertrophic cardiomyopathy and maternal
type of diabetes mellitus.
Discussion
Diabetes is a relatively common condition in pregnancy,
affecting up to 0.5% of the pregnant population [1].
r=0.260, P<0.05
Figure 4 Correlation between cTnI and posterior wall thickness.
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morbidity and mortality [2,3]. A well-recognized compli-
cation of diabetic pregnancy is the condition of hyper-
trophic cardiomyopathy. It was mentioned by vural et al.
1995 [5] that, while symptomatic hypertrophic cardio-
myopathy occurs in 12.1% of infants of diabetic mothers,
it is found in 40% when routinely searched for with an
echocardiographic scan [5-7]. The primary aim of this
study was to assess cardiac damage in infants of diabetic
mothers, as assessed by cTnI levels and to determine
whether there is a relationship between this cardiac mar-
ker and echocardiographic findings.Figure 5 M-mode and parasternal long axis view for left atrial
hypertrophy in an infant of a diabetic mother.Troponin is an inhibitory protein complex found in all
striated muscles, and the cardiac-specific isoform tropo-
nin I (cTnI) is a sensitive and specific marker of myocar-
dial ischemia [10]. Our study showed that the cTnI
concentration is unaffected by gestation, birth weight,
sex, or mode of delivery, this is inconsistent with other
publications [11]. In the current study, infants of dia-
betic mothers have increased plasma troponin I concen-
trations on the second day of life. Delivery and
cardiovascular maladaptation to extra-uterine life can
cause further compromise of oxygenation which lead to
further myocardial compromise and troponin release
[12]. Accordingly, elevations of troponin I was not
detected immediately after birth.
Cardiac troponin I level was significantly higher in
neoxnates who have respiratory distress and cyanosis
compared to the controls. These findings may be
explained in several ways. Firstly, myocardial injury
with cardiac dysfunction may result in impaired gasTable 5 Relation between cTnI and echocardiographic
findings in neonates of diabetic mothers
Present Absent z∞ P
N Median (IQR) N Median (IQR)
HCMP 32 1.3 (1.0-2.5) 8 1.0 (1.0-1.0) −2.897 0.004*
PFO 15 1.0 (1.0-1.0) 25 1.8 (1.0-3.8) −3.127 0.002*
PDA 11 1.0 (1.0-2.5) 29 1.1 (1.0-2.5) −1.006 0.315
* = Significant ∞ Mann Whitney test.
IQR = Interquartile range, HCMP = hypertrophic cardiomyopathy.
Table 6 Correlation between TnI (2nd) and
echocardiographic measurements of neonates
r# p
LVED (mm) 0.306 0.031*
LVES (mm) -0.020 0.891
FS% 0.143 0.322
EF % 0.177 0.218
PWT (mm) 0.260 0.050*
LA D (mm) 0.261 0.050*
IVSD (mm) 0.423 0.002*
* = Significant #Spearman correlation.
LVED : Left Ventrivular End Diastolic Dimension, LVES; Left Ventricular End
Systolic Dimension.
FS% : shortening fraction, EF% : Ejection fraction, PWT : Posterior wall.
Thickness, LAD: Left Atrium dimension, IVSD : Interventricular septal diameter.
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promise may have a common cause as diabetes in the
pregnant mother is strongly associated with neonatal
cardiomyopathy [11-13]. Troponin release occurs in
response to ischemia, and it is possible that diabetes-
induced placental micro vascular disease and abnor-
mal placentation may lead to chronic intrauterine
hypoxia, which could affect fetal myocardial function,
making infants of diabetic mothers more susceptible
to an acute hypoxic insult [14-16].
The thickness of the interventricular septum was
significantly more common in infants born to diabetic
mothers. Hypertrophic cardiomyopathy was found in
80% of IDMs which is often transient with no lasting
consequences for the majority of neonates [16-19]. In
this study, an important number of infants presented
with cardiorespiratory manifestations (67.5% with respi-
ratory distress and 60 % with cyanosis). These factors
reflect the problem of the higher incidence of cardiomy-
opathy in this study. Russell et al. 2008 [20] had reportedFigure 6 Apical four chamber view two-dimensional echocardiogrampreviously that stillborn infants of diabetic mothers have
heavier hearts than stillborn infants of non diabetic
mothers after correction for fetal size, suggesting that
cardiomyopathy may have a role in “unexplained”
fetal death in diabetic pregnancy [19,20]. The etiology
of this cardiomyopathy is poorly understood with
proposed mechanisms including fetal hyperglycemia,
hyperinsulinemia, and chronic hypoxia [20,21]. It has
been suggested that cardiomyopathy occurs in response
to functional changes evident in the first trimester
in fetuses of pregestational type 1 diabetic mothers
[22]. Early pregnancy hyperglycemia may also have an
effect on the developing placenta and impaired placental
functioning may result in chronic intrauterine hypoxia
causing ischemic damage to the fetal myocardium and
thus troponin release [23].
An increase in cTnI serum levels in infants with
HCMP pointed to subclinical myocyte injury. The
mechanisms of myocyte injury in HCMP are not fully
understood. It may be caused by relative myocardial
ischemia resulting from an imbalance between in-
appropriate hypertrophy of the myocardium and in-
sufficient oxygen supply [20,22]. Left ventricular
contractility as assessed by the ejection fraction and
percentage shortening of the internal thickness was
higher in infants of diabetic mothers compared with
the controls. This finding could reflect myocardial
compromise or an increase in the ventricular work-
load [24]. These data suggest that maternal diabetes
is associated with significant effects on neonatal car-
diac function with correlation between interventricu-
lar septal diameter and troponin I release in diabetic
pregnancy. Poor glycemic control in early pregnancy
changes fetal cardiac gene activation and predisposes
the fetus to myocardial hypertrophy [24,25].
The findings in this work suggest that cTnI is a bio-
chemical marker as sensitive as echocardiographicshowing septal hypertrophy in an infant of diabetic mother.
Figure 7 M-mode and parasternal long axis view showing interventricular septal hypertrophy in an infant of a diabetic mother.
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and should be done to any infant born to a diabetic
mother suffering from respiratory distress.Conclusions
Cardiac troponin I (cTnI) is a useful biochemical marker
for monitoring myocardial injury in infants of diabetic
mothers. It is a sensitive marker so as echocardiographic
measurements in detection of cardiac dysfunction. It
should be estimated in any infant born to a diabeticTable 7 Correlation between TnI (2nd) and both clinical &
laboratory findings of infants of diabetic mothers
r# p
Gestational age 0.106 0.463
Birth wt. 0.213 0.137
APGAR 1 −0.121 0.401
APGAR 2 0.000 1.000
RBS (mg/dl) −0.214 0.136
CRP ( mg/L) −0.112 0.439
PH (mmHg) −0.035 0.812
PCO2 (mmHg) −0.050 0.732
PO2 (mmHg) 0.174 0.227
HCo3 (mmol/L) −0.165 0.253
BEe (mmol/L) −0.156 0.280
*Significant #Spearman correlation.
RBS: Random Blood Suger, CRP: C- Reactive protein, BE: Base excess.mother, mostly in those who present respiratory distress
as it can predict hypertrophic cardiomyopathy and/or
left ventricular dysfunction.
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